Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum
- PMID: 12668049
- DOI: 10.1016/s0028-3908(03)00029-7
Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum
Abstract
Cannabinoids are known to exert mainly excitatory effects on dopaminergic cells of the ventral tegmental area (VTA). We have utilized an in vivo multiple-single unit electrophysiological approach to assess different neuronal contributions that may ultimately lead to excitation in this area. Baseline neuron recordings, using low impedance microwires, showed a variety of waveforms with a wide range of durations (0.8-3.2 ms). In the first experiment systemic injection of the potent cannabinoid agonist HU210 (100 microg/kg, i.p.) led predominantly to an increase in firing rate (approximately 214%, compared to pre-drug) in slowly firing cells with broad action potentials, possibly driven by a majority of presumed dopaminergic neurons (n = 31). However, the firing rate of some units was either unaffected (<25%, n = 9) or even decreased (approximately 67%, n = 9) following cannabinoid injection concomitantly with excitation. Apomorphine (75 microg/kg, i.p.) injected following HU210 produced a marked inhibition of both responses (approximately 76%) in 39 out of 49 cells. The second group of animals was treated with the CB(1) receptor antagonist SR141716A (1 mg/kg, i.p.), which had no effect when injected alone but prevented all HU210-evoked changes in firing rate suggesting that cannabinoid receptors mediated the observed responses (n = 39). Taken together, the present results suggest that the observed actions of cannabinoids may involve complex neurotransmitter interactions leading to differential effects on dopamine release. These heterogeneous neuronal responses are likely to underly the behavioural discrepancies reported in animal models of cannabinoid reinforcement.
Similar articles
-
Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.Neuroscience. 2000;99(4):661-7. doi: 10.1016/s0306-4522(00)00241-4. Neuroscience. 2000. PMID: 10974429
-
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.Eur J Neurosci. 2001 Jul;14(1):96-102. doi: 10.1046/j.0953-816x.2001.01612.x. Eur J Neurosci. 2001. PMID: 11488953
-
delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.Neurosci Lett. 1997 May 2;226(3):159-62. doi: 10.1016/s0304-3940(97)00278-4. Neurosci Lett. 1997. PMID: 9175591
-
Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.Eur J Neurosci. 2000 Jun;12(6):2079-86. doi: 10.1046/j.1460-9568.2000.00101.x. Eur J Neurosci. 2000. PMID: 10886347
-
Hu 210: a potent tool for investigations of the cannabinoid system.CNS Drug Rev. 2001 Summer;7(2):131-45. doi: 10.1111/j.1527-3458.2001.tb00192.x. CNS Drug Rev. 2001. PMID: 11474421 Free PMC article. Review.
Cited by
-
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.J Neurosci. 2016 Oct 5;36(40):10230-10238. doi: 10.1523/JNEUROSCI.1712-16.2016. J Neurosci. 2016. PMID: 27707960 Free PMC article. Review.
-
Endocannabinoids in Body Weight Control.Pharmaceuticals (Basel). 2018 May 30;11(2):55. doi: 10.3390/ph11020055. Pharmaceuticals (Basel). 2018. PMID: 29849009 Free PMC article. Review.
-
Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats.Psychopharmacology (Berl). 2008 Jun;198(3):375-85. doi: 10.1007/s00213-008-1148-1. Epub 2008 Apr 30. Psychopharmacology (Berl). 2008. PMID: 18446326
-
Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain.Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):516-24. doi: 10.1007/s00210-004-0921-x. Epub 2004 Apr 3. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15064921
-
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):345-69. doi: 10.1007/s00210-008-0327-2. Epub 2008 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18654765 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources